{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T05:33:00Z","timestamp":1794893580930,"version":"4.9.1"},"reference-count":179,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T00:00:00Z","timestamp":1769040000000},"content-version":"vor","delay-in-days":52,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Tumor immunotherapy has significantly advanced in recent years. However, few patients with solid tumors respond to immunotherapy. The tumor microenvironment (TME) is a key factor in immunotherapy efficacy, and the intratumoral microbiota plays a significant role in remodeling the TME. Recent multiomic analyses revealed bacterial signatures in up to 76% of pancreatic ductal adenocarcinoma (PDAC) cases, and specific microbial consortia were linked to therapeutic resistance. Microbiota-targeted therapies, such as engineered bacterial strains, increase tumor clearance rates by approximately 30% in preclinical models. However, the complexity of microbial mechanisms and heterogeneity among individuals limit the clinical translation of intratumoral microbiota-based therapies. In this review, we provide an overview of intratumoral microorganisms, explore their influence on immune cells and signaling pathways in the TME, and discuss their potential value for improving the response of solid tumors to immunotherapy. Specifically, we examine the unique characteristics of intratumoral microbes in different types of solid tumors, emphasizing how tumor microsatellite status plays a key role in determining the effects of intratumoral microbes on the response of solid tumors to immunotherapy. Additionally, we discuss the clinical application of the intratumoral microbiota as a potential method for improving treatment efficacy and prognosis prediction in patients receiving immunotherapy for solid tumors.<\/jats:p>","DOI":"10.1038\/s41419-025-08211-w","type":"journal-article","created":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T18:53:34Z","timestamp":1764615214000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Intratumoral microbiota remodeling of the tumor microenvironment impact solid tumor immunotherapy"],"prefix":"10.1038","volume":"17","author":[{"given":"Jiawen","family":"Jia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenwen","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiqian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9098-7296","authenticated-orcid":false,"given":"Zhenqiang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cuiping","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6534-6991","authenticated-orcid":false,"given":"Yongbin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haibin","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-4303-9789","authenticated-orcid":false,"given":"Yan","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,1]]},"reference":[{"key":"8211_CR1","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/s41423-020-0488-6","volume":"17","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Zhang Z. The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications. Cell Mol Immunol. 2020;17:807\u201321.","journal-title":"Cell Mol Immunol"},{"key":"8211_CR2","volume":"4","author":"C Xue","year":"2023","unstructured":"Xue C, Chu Q, Zheng Q, Yuan X, Su Y, Bao Z, et al. Current understanding of the intratumoral microbiome in various tumors. Cell Rep Med. 2023;4:100884.","journal-title":"Cell Rep Med"},{"key":"8211_CR3","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.3390\/ijms22031446","volume":"22","author":"M Oliva","year":"2021","unstructured":"Oliva M, Mulet-Margalef N, Ochoa-De-Olza M, Napoli S, Mas J, Laquente B, et al. Tumor-associated microbiome: Where do we stand?. Int J Mol Sci. 2021;22:1446.","journal-title":"Int J Mol Sci"},{"key":"8211_CR4","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/s41392-022-01304-4","volume":"8","author":"L Yang","year":"2023","unstructured":"Yang L, Li A, Wang Y, Zhang Y. Intratumoral microbiota: roles in cancer initiation, development and therapeutic efficacy. Signal Transduct Target Ther. 2023;8:35.","journal-title":"Signal Transduct Target Ther"},{"key":"8211_CR5","volume":"9","author":"Y Xie","year":"2022","unstructured":"Xie Y, Xie F, Zhou X, Zhang L, Yang B, Huang J, et al. Microbiota in tumors: from understanding to application. Adv Sci Weinh Baden-Wurtt Ger. 2022;9:e2200470.","journal-title":"Adv Sci Weinh Baden-Wurtt Ger"},{"key":"8211_CR6","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/s41392-023-01693-0","volume":"9","author":"Y Cao","year":"2024","unstructured":"Cao Y, Xia H, Tan X, Shi C, Ma Y, Meng D, et al. Intratumoural microbiota: a new frontier in cancer development and therapy. Signal Transduct Target Ther. 2024;9:15.","journal-title":"Signal Transduct Target Ther"},{"key":"8211_CR7","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.tim.2024.01.007","volume":"32","author":"Y-Q Lu","year":"2024","unstructured":"Lu Y-Q, Qiao H, Tan X-R, Liu N. Broadening oncological boundaries: the intratumoral microbiota. Trends Microbiol. 2024;32:807\u201322.","journal-title":"Trends Microbiol"},{"key":"8211_CR8","doi-asserted-by":"crossref","first-page":"C1433","DOI":"10.1152\/ajpcell.00201.2024","volume":"327","author":"S Ciernikova","year":"2024","unstructured":"Ciernikova S, Sevcikova A, Mego M. Targeting the gut and tumor microbiome in cancer treatment resistance. Am J Physiol Cell Physiol. 2024;327:C1433\u201350.","journal-title":"Am J Physiol Cell Physiol"},{"key":"8211_CR9","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1126\/science.aay9189","volume":"368","author":"D Nejman","year":"2020","unstructured":"Nejman D, Livyatan I, Fuks G, Gavert N, Zwang Y, Geller LT, et al. The human tumor microbiome is composed of tumor type-specific intracellular bacteria. Science. 2020;368:973\u201380.","journal-title":"Science"},{"key":"8211_CR10","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.cell.2019.07.008","volume":"178","author":"E Riquelme","year":"2019","unstructured":"Riquelme E, Zhang Y, Zhang L, Montiel M, Zoltan M, Dong W, et al. Tumor microbiome diversity and composition influence pancreatic cancer outcomes. Cell. 2019;178:795\u2013806.e12.","journal-title":"Cell"},{"key":"8211_CR11","volume":"1878","author":"A Bahuguna","year":"2023","unstructured":"Bahuguna A, Dubey SK. Relevance of tumor microbiome in cancer incidence, prognosis, and its clinical implications in therapeutics. Biochim Biophys Acta BBA Rev Cancer. 2023;1878:188956.","journal-title":"Biochim Biophys Acta BBA Rev Cancer"},{"key":"8211_CR12","doi-asserted-by":"crossref","first-page":"3789","DOI":"10.1016\/j.cell.2022.09.005","volume":"185","author":"L Narunsky-Haziza","year":"2022","unstructured":"Narunsky-Haziza L, Sepich-Poore GD, Livyatan I, Asraf O, Martino C, Nejman D, et al. Pan-cancer analyses reveal cancer-type-specific fungal ecologies and bacteriome interactions. Cell. 2022;185:3789\u20133806.e17.","journal-title":"Cell"},{"key":"8211_CR13","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2022.2156255","volume":"15","author":"X Chai","year":"2023","unstructured":"Chai X, Wang J, Li H, Gao C, Li S, Wei C, et al. Intratumor microbiome features reveal antitumor potentials of intrahepatic cholangiocarcinoma. Gut Microbes. 2023;15:2156255.","journal-title":"Gut Microbes"},{"key":"8211_CR14","volume":"13","author":"X Yang","year":"2023","unstructured":"Yang X, An H, He Y, Fu G, Jiang Z. Comprehensive analysis of microbiota signature across 32 cancer types. Front Oncol. 2023;13:1127225.","journal-title":"Front Oncol"},{"key":"8211_CR15","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/j.ccell.2021.08.006","volume":"39","author":"N Cullin","year":"2021","unstructured":"Cullin N, Azevedo Antunes C, Straussman R, Stein-Thoeringer CK, Elinav E. Microbiome and cancer. Cancer Cell. 2021;39:1317\u201341.","journal-title":"Cancer Cell"},{"key":"8211_CR16","doi-asserted-by":"crossref","first-page":"3115","DOI":"10.3390\/ijms21093115","volume":"21","author":"MM Azevedo","year":"2020","unstructured":"Azevedo MM, Pina-Vaz C, Baltazar F. Microbes and cancer: friends or faux?. Int J Mol Sci. 2020;21:3115.","journal-title":"Int J Mol Sci"},{"key":"8211_CR17","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.chom.2020.08.003","volume":"28","author":"AC Gregory","year":"2020","unstructured":"Gregory AC, Zablocki O, Zayed AA, Howell A, Bolduc B, Sullivan MB. The Gut Virome Database Reveals Age-Dependent Patterns of Virome Diversity in the Human Gut. Cell Host Microbe. 2020;28:724\u201340.e8.","journal-title":"Cell Host Microbe"},{"key":"8211_CR18","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1093\/infdis\/jiz318","volume":"220","author":"S Mollerup","year":"2019","unstructured":"Mollerup S, Asplund M, Friis-Nielsen J, Kjartansd\u00f3ttir KR, Fridholm H, Hansen TA, et al. High-throughput sequencing-based investigation of viruses in human cancers by multienrichment approach. J Infect Dis. 2019;220:1312\u201324.","journal-title":"J Infect Dis"},{"key":"8211_CR19","doi-asserted-by":"crossref","first-page":"5126","DOI":"10.1002\/jmv.26887","volume":"93","author":"H-Z Cai","year":"2021","unstructured":"Cai H-Z, Zhang H, Yang J, Zeng J, Wang H. Preliminary assessment of viral metagenome from cancer tissue and blood from patients with lung adenocarcinoma. J Med Virol. 2021;93:5126\u201333.","journal-title":"J Med Virol"},{"key":"8211_CR20","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-020-16967-2","volume":"11","author":"L Parhi","year":"2020","unstructured":"Parhi L, Alon-Maimon T, Sol A, Nejman D, Shhadeh A, Fainsod-Levi T, et al. Breast cancer colonization by Fusobacterium nucleatum accelerates tumor growth and metastatic progression. Nat Commun. 2020;11:3259.","journal-title":"Nat Commun"},{"key":"8211_CR21","volume":"13","author":"Q Tang","year":"2022","unstructured":"Tang Q, Peng X, Xu B, Zhou X, Chen J, Cheng L. Current status and future directions of bacteria-based immunotherapy. Front Immunol. 2022;13:911783.","journal-title":"Front Immunol"},{"key":"8211_CR22","volume":"19","author":"N Zhang","year":"2020","unstructured":"Zhang N, Nan A, Chen L, Li X, Jia Y, Qiu M, et al. Circular RNA circSATB2 promotes progression of non-small cell lung cancer cells. Mol Cancer. 2020;19:101.","journal-title":"Mol Cancer"},{"key":"8211_CR23","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.canlet.2018.04.026","volume":"428","author":"X Zhao","year":"2018","unstructured":"Zhao X, Wu X, Qian M, Song Y, Wu D, Zhang W. Knockdown of TGF-\u03b21 expression in human umbilical cord mesenchymal stem cells reverts their exosome-mediated EMT promoting effect on lung cancer cells. Cancer Lett. 2018;428:34\u201344.","journal-title":"Cancer Lett"},{"key":"8211_CR24","first-page":"1","volume":"51","author":"DH Kim","year":"2019","unstructured":"Kim DH, Kim H, Choi YJ, Kim SY, Lee J-E, Sung KJ, et al. Exosomal PD-L1 promotes tumor growth through immune escape in non-small cell lung cancer. Exp Mol Med. 2019;51:1\u201313.","journal-title":"Exp Mol Med"},{"key":"8211_CR25","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.canlet.2015.10.011","volume":"370","author":"Y Liu","year":"2016","unstructured":"Liu Y, Luo F, Wang B, Li H, Xu Y, Liu X, et al. STAT3-regulated exosomal miR-21 promotes angiogenesis and is involved in neoplastic processes of transformed human bronchial epithelial cells. Cancer Lett. 2016;370:125\u201335.","journal-title":"Cancer Lett"},{"key":"8211_CR26","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/s42255-020-0219-4","volume":"2","author":"T Wang","year":"2020","unstructured":"Wang T, Gnanaprakasam JNR, Chen X, Kang S, Xu X, Sun H, et al. Inosine is an alternative carbon source for CD8+-T-cell function under glucose restriction. Nat Metab. 2020;2:635\u201347.","journal-title":"Nat Metab"},{"key":"8211_CR27","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/s41564-019-0649-5","volume":"5","author":"E Zagato","year":"2020","unstructured":"Zagato E, Pozzi C, Bertocchi A, Schioppa T, Saccheri F, Guglietta S, et al. Endogenous murine microbiota member Faecalibaculum rodentium and its human homologue protect from intestinal tumour growth. Nat Microbiol. 2020;5:511\u201324.","journal-title":"Nat Microbiol"},{"key":"8211_CR28","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1126\/science.abc3421","volume":"369","author":"LF Mager","year":"2020","unstructured":"Mager LF, Burkhard R, Pett N, Cooke NCA, Brown K, Ramay H, et al. Microbiome-derived inosine modulates response to checkpoint inhibitor immunotherapy. Science. 2020;369:1481\u20139.","journal-title":"Science"},{"key":"8211_CR29","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.ccell.2020.09.005","volume":"38","author":"E Allen-Vercoe","year":"2020","unstructured":"Allen-Vercoe E, Coburn B. A microbiota-derived metabolite augments cancer immunotherapy responses in mice. Cancer Cell. 2020;38:452\u20133.","journal-title":"Cancer Cell"},{"key":"8211_CR30","first-page":"327","volume":"40","author":"J Ma","year":"2021","unstructured":"Ma J, Huang L, Hu D, Zeng S, Han Y, Shen H. The role of the tumor microbe microenvironment in the tumor immune microenvironment: bystander, activator, or inhibitor?. J Exp Clin Cancer Res CR. 2021;40:327.","journal-title":"J Exp Clin Cancer Res CR"},{"key":"8211_CR31","doi-asserted-by":"crossref","first-page":"5972","DOI":"10.1158\/1078-0432.CCR-19-0094","volume":"25","author":"W Tang","year":"2019","unstructured":"Tang W, Putluri V, Ambati CR, Dorsey TH, Putluri N, Ambs S. Liver- and microbiome-derived bile acids accumulate in human breast tumors and inhibit growth and improve patient survival. Clin Cancer Res J Am Assoc Cancer Res. 2019;25:5972\u201383.","journal-title":"Clin Cancer Res J Am Assoc Cancer Res"},{"key":"8211_CR32","doi-asserted-by":"crossref","first-page":"3147","DOI":"10.1002\/ijc.32920","volume":"146","author":"A Lop\u00e8s","year":"2020","unstructured":"Lop\u00e8s A, Billard E, Casse AH, Vill\u00e9ger R, Veziant J, Roche G, et al. Colibactin-positive Escherichia coli induce a procarcinogenic immune environment leading to immunotherapy resistance in colorectal cancer. Int J Cancer. 2020;146:3147\u201359.","journal-title":"Int J Cancer"},{"key":"8211_CR33","volume":"21","author":"Y He","year":"2023","unstructured":"He Y, Zhang Q, Yu X, Zhang S, Guo W. Overview of microbial profiles in human hepatocellular carcinoma and adjacent nontumor tissues. J Transl Med. 2023;21:68.","journal-title":"J Transl Med"},{"key":"8211_CR34","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/s41392-020-00449-4","volume":"6","author":"T Tang","year":"2021","unstructured":"Tang T, Huang X, Zhang G, Hong Z, Bai X, Liang T. Advantages of targeting the tumor immune microenvironment over blocking immune checkpoint in cancer immunotherapy. Signal Transduct Target Ther. 2021;6:72.","journal-title":"Signal Transduct Target Ther"},{"key":"8211_CR35","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/s41591-018-0014-x","volume":"24","author":"M Binnewies","year":"2018","unstructured":"Binnewies M, Roberts EW, Kersten K, Chan V, Fearon DF, Merad M, et al. Understanding the tumor immune microenvironment (TIME) for effective therapy. Nat Med. 2018;24:541\u201350.","journal-title":"Nat Med"},{"key":"8211_CR36","volume":"19","author":"D Ren","year":"2020","unstructured":"Ren D, Hua Y, Yu B, Ye X, He Z, Li C, et al. Predictive biomarkers and mechanisms underlying resistance to PD1\/PD-L1 blockade cancer immunotherapy. Mol Cancer. 2020;19:19.","journal-title":"Mol Cancer"},{"key":"8211_CR37","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1136\/gutjnl-2015-310101","volume":"65","author":"K Mima","year":"2016","unstructured":"Mima K, Nishihara R, Qian ZR, Cao Y, Sukawa Y, Nowak JA, et al. Fusobacterium nucleatum in colorectal carcinoma tissue and patient prognosis. Gut. 2016;65:1973\u201380.","journal-title":"Gut"},{"key":"8211_CR38","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1158\/1078-0432.CCR-20-4009","volume":"27","author":"J Borowsky","year":"2021","unstructured":"Borowsky J, Haruki K, Lau MC, Dias Costa A, V\u00e4yrynen JP, Ugai T, et al. Association of fusobacterium nucleatum with specific T-cell subsets in the colorectal carcinoma microenvironment. Clin Cancer Res J Am Assoc Cancer Res. 2021;27:2816\u201326.","journal-title":"Clin Cancer Res J Am Assoc Cancer Res"},{"key":"8211_CR39","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.humpath.2018.05.008","volume":"79","author":"T Chen","year":"2018","unstructured":"Chen T, Li Q, Zhang X, Long R, Wu Y, Wu J, et al. TOX expression decreases with progression of colorectal cancers and is associated with CD4 T-cell density and Fusobacterium nucleatum infection. Hum Pathol. 2018;79:93\u2013101.","journal-title":"Hum Pathol"},{"key":"8211_CR40","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/s41421-024-00746-0","volume":"10","author":"L Yuan","year":"2024","unstructured":"Yuan L, Pan L, Wang Y, Zhao J, Fang L, Zhou Y, et al. Characterization of the landscape of the intratumoral microbiota reveals that Streptococcus anginosus increases the risk of gastric cancer initiation and progression. Cell Discov. 2024;10:117.","journal-title":"Cell Discov"},{"key":"8211_CR41","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2021.1988403","volume":"10","author":"M Boesch","year":"2021","unstructured":"Boesch M, Baty F, Albrich WC, Flatz L, Rodriguez R, Rothschild SI, et al. Local tumor microbial signatures and response to checkpoint blockade in non-small cell lung cancer. Oncoimmunology. 2021;10:1988403.","journal-title":"Oncoimmunology"},{"key":"8211_CR42","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-018-03900-x","volume":"9","author":"JF Anker","year":"2018","unstructured":"Anker JF, Naseem AF, Mok H, Schaeffer AJ, Abdulkadir SA, Thumbikat P. Multi-faceted immunomodulatory and tissue-tropic clinical bacterial isolate potentiates prostate cancer immunotherapy. Nat Commun. 2018;9:1591.","journal-title":"Nat Commun"},{"key":"8211_CR43","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1016\/j.cell.2024.03.037","volume":"187","author":"H Chi","year":"2024","unstructured":"Chi H, Pepper M, Thomas PG. Principles and therapeutic applications of adaptive immunity. Cell. 2024;187:2052\u201378.","journal-title":"Cell"},{"key":"8211_CR44","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.cell.2018.12.040","volume":"176","author":"C Jin","year":"2019","unstructured":"Jin C, Lagoudas GK, Zhao C, Bullman S, Bhutkar A, Hu B, et al. Commensal microbiota promote lung cancer development via \u03b3\u03b4 T cells. Cell. 2019;176:998\u20131013.e16.","journal-title":"Cell"},{"key":"8211_CR45","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/s41577-018-0009-3","volume":"18","author":"P Golstein","year":"2018","unstructured":"Golstein P, Griffiths GM. An early history of T cell-mediated cytotoxicity. Nat Rev Immunol. 2018;18:527\u201335.","journal-title":"Nat Rev Immunol"},{"key":"8211_CR46","doi-asserted-by":"crossref","first-page":"3131","DOI":"10.1158\/0008-5472.CAN-22-2593","volume":"83","author":"H Wu","year":"2023","unstructured":"Wu H, Leng X, Liu Q, Mao T, Jiang T, Liu Y, et al. Intratumoral microbiota composition regulates chemoimmunotherapy response in esophageal squamous cell carcinoma. Cancer Res. 2023;83:3131\u201344.","journal-title":"Cancer Res"},{"key":"8211_CR47","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1016\/j.cell.2023.03.011","volume":"186","author":"MJ Bender","year":"2023","unstructured":"Bender MJ, McPherson AC, Phelps CM, Pandey SP, Laughlin CR, Shapira JH, et al. Dietary tryptophan metabolite released by intratumoral Lactobacillus reuteri facilitates immune checkpoint inhibitor treatment. Cell. 2023;186:1846\u201362.e26.","journal-title":"Cell"},{"key":"8211_CR48","first-page":"25","volume":"151","author":"G Zhu","year":"2021","unstructured":"Zhu G, Su H, Johnson CH, Khan SA, Kluger H, Lu L. Intratumour microbiome associated with the infiltration of cytotoxic CD8+ T cells and patient survival in cutaneous melanoma. Eur J Cancer Oxf Engl 1990. 2021;151:25\u201334.","journal-title":"Eur J Cancer Oxf Engl 1990"},{"key":"8211_CR49","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s00281-019-00744-5","volume":"41","author":"M Kurachi","year":"2019","unstructured":"Kurachi M. CD8+ T cell exhaustion. Semin Immunopathol. 2019;41:327\u201337.","journal-title":"Semin Immunopathol"},{"key":"8211_CR50","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1158\/2326-6066.CIR-22-0107","volume":"10","author":"R Peng","year":"2022","unstructured":"Peng R, Liu S, You W, Huang Y, Hu C, Gao Y, et al. Gastric microbiome alterations are associated with decreased CD8+ tissue-resident memory T cells in the tumor microenvironment of gastric cancer. Cancer Immunol Res. 2022;10:1224\u201340.","journal-title":"Cancer Immunol Res"},{"key":"8211_CR51","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.chom.2023.04.010","volume":"31","author":"S-S Jiang","year":"2023","unstructured":"Jiang S-S, Xie Y-L, Xiao X-Y, Kang Z-R, Lin X-L, Zhang L, et al. Fusobacterium nucleatum-derived succinic acid induces tumor resistance to immunotherapy in colorectal cancer. Cell Host Microbe. 2023;31:781\u201397.e9.","journal-title":"Cell Host Microbe"},{"key":"8211_CR52","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.ccell.2023.02.016","volume":"41","author":"KE de Visser","year":"2023","unstructured":"de Visser KE, Joyce JA. The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth. Cancer Cell. 2023;41:374\u2013403.","journal-title":"Cancer Cell"},{"key":"8211_CR53","doi-asserted-by":"crossref","first-page":"9999","DOI":"10.1073\/pnas.1822001116","volume":"116","author":"T Kamada","year":"2019","unstructured":"Kamada T, Togashi Y, Tay C, Ha D, Sasaki A, Nakamura Y, et al. PD-1+regulatory T cells amplified by PD-1 blockade promote hyperprogression of cancer. Proc Natl Acad Sci. 2019;116:9999\u201310008.","journal-title":"Proc Natl Acad Sci"},{"key":"8211_CR54","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.01497-21","volume":"9","author":"S Davidsson","year":"2021","unstructured":"Davidsson S, Carlsson J, Greenberg L, Wijkander J, S\u00f6derquist B, Erlandsson A. Cutibacterium acnes induces the expression of immunosuppressive genes in macrophages and is associated with an increase of regulatory T-cells in prostate cancer. Microbiol Spectr. 2021;9:e0149721.","journal-title":"Microbiol Spectr"},{"key":"8211_CR55","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s00262-020-02657-x","volume":"70","author":"JA Lee","year":"2021","unstructured":"Lee JA, Yoo S-Y, Oh HJ, Jeong S, Cho N-Y, Kang GH, et al. Differential immune microenvironmental features of microsatellite-unstable colorectal cancers according to Fusobacterium nucleatum status. Cancer Immunol Immunother CII. 2021;70:47\u201359.","journal-title":"Cancer Immunol Immunother CII"},{"key":"8211_CR56","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abn0704","volume":"7","author":"G Mirji","year":"2022","unstructured":"Mirji G, Worth A, Bhat SA, El Sayed M, Kannan T, Goldman AR, et al. The microbiome-derived metabolite TMAO drives immune activation and boosts responses to immune checkpoint blockade in pancreatic cancer. Sci Immunol. 2022;7:eabn0704.","journal-title":"Sci Immunol"},{"key":"8211_CR57","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.trecan.2023.03.005","volume":"9","author":"V Ferrari","year":"2023","unstructured":"Ferrari V, Rescigno M. The intratumoral microbiota: friend or foe?. Trends Cancer. 2023;9:472\u20139.","journal-title":"Trends Cancer"},{"key":"8211_CR58","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/s41571-020-0426-7","volume":"18","author":"JA Myers","year":"2021","unstructured":"Myers JA, Miller JS. Exploring the NK cell platform for cancer immunotherapy. Nat Rev Clin Oncol. 2021;18:85\u2013100.","journal-title":"Nat Rev Clin Oncol"},{"key":"8211_CR59","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.immuni.2015.01.010","volume":"42","author":"C Gur","year":"2015","unstructured":"Gur C, Ibrahim Y, Isaacson B, Yamin R, Abed J, Gamliel M, et al. Binding of the Fap2 protein of Fusobacterium nucleatum to human inhibitory receptor TIGIT protects tumors from immune cell attack. Immunity. 2015;42:344\u201355.","journal-title":"Immunity"},{"key":"8211_CR60","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abg5016","volume":"7","author":"ZA Rizvi","year":"2021","unstructured":"Rizvi ZA, Dalal R, Sadhu S, Kumar Y, Kumar S, Gupta SK, et al. High-salt diet mediates interplay between NK cells and gut microbiota to induce potent tumor immunity. Sci Adv. 2021;7:eabg5016.","journal-title":"Sci Adv"},{"key":"8211_CR61","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s13045-024-01559-0","volume":"17","author":"B Toledo","year":"2024","unstructured":"Toledo B, Zhu Chen L, Paniagua-Sancho M, Marchal JA, Per\u00e1n M, Giovannetti E. Deciphering the performance of macrophages in tumour microenvironment: a call for precision immunotherapy. J Hematol Oncol J Hematol Oncol. 2024;17:44.","journal-title":"J Hematol Oncol J Hematol Oncol"},{"key":"8211_CR62","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.cell.2016.03.001","volume":"165","author":"L Zitvogel","year":"2016","unstructured":"Zitvogel L, Ayyoub M, Routy B, Kroemer G. Microbiome and anticancer immunosurveillance. Cell. 2016;165:276\u201387.","journal-title":"Cell"},{"key":"8211_CR63","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1158\/2159-8290.CD-17-1134","volume":"8","author":"S Pushalkar","year":"2018","unstructured":"Pushalkar S, Hundeyin M, Daley D, Zambirinis CP, Kurz E, Mishra A, et al. The pancreatic cancer microbiome promotes oncogenesis by induction of innate and adaptive immune suppression. Cancer Discov. 2018;8:403\u201316.","journal-title":"Cancer Discov"},{"key":"8211_CR64","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1007\/s00262-018-2233-x","volume":"67","author":"T Chen","year":"2018","unstructured":"Chen T, Li Q, Wu J, Wu Y, Peng W, Li H, et al. Fusobacterium nucleatum promotes M2 polarization of macrophages in the microenvironment of colorectal tumours via a TLR4-dependent mechanism. Cancer Immunol Immunother CII. 2018;67:1635\u201346.","journal-title":"Cancer Immunol Immunother CII"},{"key":"8211_CR65","volume":"9","author":"S Han","year":"2023","unstructured":"Han S, Bao X, Zou Y, Wang L, Li Y, Yang L, et al. d-lactate modulates M2 tumor-associated macrophages and remodels immunosuppressive tumor microenvironment for hepatocellular carcinoma. Sci Adv. 2023;9:eadg2697.","journal-title":"Sci Adv"},{"key":"8211_CR66","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.3389\/fimmu.2017.01383","volume":"8","author":"E M\u00fcller","year":"2017","unstructured":"M\u00fcller E, Christopoulos PF, Halder S, Lunde A, Beraki K, Speth M, et al. Toll-like receptor ligands and interferon-\u03b3 synergize for induction of antitumor M1 macrophages. Front Immunol. 2017;8:1383.","journal-title":"Front Immunol"},{"key":"8211_CR67","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.cmet.2019.06.001","volume":"30","author":"I Vitale","year":"2019","unstructured":"Vitale I, Manic G, Coussens LM, Kroemer G, Galluzzi L. Macrophages and metabolism in the tumor microenvironment. Cell Metab. 2019;30:36\u201350.","journal-title":"Cell Metab"},{"key":"8211_CR68","volume":"74","author":"J Wu","year":"2019","unstructured":"Wu J, Li K, Peng W, Li H, Li Q, Wang X, et al. Autoinducer-2 of Fusobacterium nucleatum promotes macrophage M1 polarization via TNFSF9\/IL-1\u03b2 signaling. Int Immunopharmacol. 2019;74:105724.","journal-title":"Int Immunopharmacol"},{"key":"8211_CR69","doi-asserted-by":"crossref","first-page":"5338","DOI":"10.1016\/j.cell.2021.09.019","volume":"184","author":"KC Lam","year":"2021","unstructured":"Lam KC, Araya RE, Huang A, Chen Q, Di Modica M, Rodrigues RR, et al. Microbiota triggers STING-type I IFN-dependent monocyte reprogramming of the tumor microenvironment. Cell. 2021;184:5338\u201356.e21.","journal-title":"Cell"},{"key":"8211_CR70","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.immuni.2022.01.006","volume":"55","author":"K Hezaveh","year":"2022","unstructured":"Hezaveh K, Shinde RS, Kl\u00f6tgen A, Halaby MJ, Lamorte S, Ciudad MT, et al. Tryptophan-derived microbial metabolites activate the aryl hydrocarbon receptor in tumor-associated macrophages to suppress anti-tumor immunity. Immunity. 2022;55:324\u201340.e8.","journal-title":"Immunity"},{"key":"8211_CR71","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1126\/science.aac4255","volume":"350","author":"A Sivan","year":"2015","unstructured":"Sivan A, Corrales L, Hubert N, Williams JB, Aquino-Michaels K, Earley ZM, et al. Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy. Science. 2015;350:1084\u20139.","journal-title":"Science"},{"key":"8211_CR72","doi-asserted-by":"crossref","first-page":"e1553487","DOI":"10.1080\/2162402X.2018.1553487","volume":"8","author":"C Gur","year":"2019","unstructured":"Gur C, Maalouf N, Gerhard M, Singer BB, Emg\u00e5rd J, Temper V, et al. The Helicobacter pylori HopQ outermembrane protein inhibits immune cell activities. Oncoimmunology. 2019;8:e1553487.","journal-title":"Oncoimmunology"},{"key":"8211_CR73","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2022.108114","volume":"235","author":"S Joshi","year":"2022","unstructured":"Joshi S, Sharabi A. Targeting myeloid-derived suppressor cells to enhance natural killer cell-based immunotherapy. Pharm Ther. 2022;235:108114.","journal-title":"Pharm Ther"},{"key":"8211_CR74","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1016\/j.ccell.2023.08.012","volume":"41","author":"N-N Liu","year":"2023","unstructured":"Liu N-N, Yi C-X, Wei L-Q, Zhou J-A, Jiang T, Hu C-C, et al. The intratumor mycobiome promotes lung cancer progression via myeloid-derived suppressor cells. Cancer Cell. 2023;41:1927\u20131944.e9.","journal-title":"Cancer Cell"},{"key":"8211_CR75","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.trecan.2024.02.009","volume":"10","author":"W Liu","year":"2024","unstructured":"Liu W, Pi Z, Liu N-N, Mao W. Into the era of mycobiome-driven cancer research. Trends Cancer. 2024;10:389\u201392.","journal-title":"Trends Cancer"},{"key":"8211_CR76","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1146\/annurev-pathmechdis-051222-015009","volume":"19","author":"A Aroca-Crevill\u00e9n","year":"2024","unstructured":"Aroca-Crevill\u00e9n A, Vicanolo T, Ovadia S, Hidalgo A. Neutrophils in physiology and pathology. Annu Rev Pathol Mech Dis. 2024;19:227\u201359.","journal-title":"Annu Rev Pathol Mech Dis"},{"key":"8211_CR77","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/s41423-025-01283-w","volume":"22","author":"JA Szlachetko","year":"2025","unstructured":"Szlachetko JA, Hofmann-Vega F, Budeus B, Schr\u00f6der L-J, Dumitru CA, Schmidt M, et al. Tumor cells that resist neutrophil anticancer cytotoxicity acquire a prometastatic and innate immune escape phenotype. Cell Mol Immunol. 2025;22:527\u201340.","journal-title":"Cell Mol Immunol"},{"key":"8211_CR78","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1158\/0008-5472.CAN-24-2580","volume":"85","author":"T Zhang","year":"2025","unstructured":"Zhang T, Li Y, Zhai E, Zhao R, Qian Y, Huang Z, et al. Intratumoral Fusobacterium nucleatum recruits tumor-associated neutrophils to promote gastric cancer progression and immune evasion. Cancer Res. 2025;85:1819\u201341.","journal-title":"Cancer Res"},{"key":"8211_CR79","volume":"14","author":"R-Y Chen","year":"2023","unstructured":"Chen R-Y, Zhu Y, Shen Y-Y, Xu Q-Y, Tang H-Y, Cui N-X, et al. The role of PD-1 signaling in health and immune-related diseases. Front Immunol. 2023;14:1163633.","journal-title":"Front Immunol"},{"key":"8211_CR80","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105543","volume":"167","author":"D Long","year":"2021","unstructured":"Long D, Liu M, Li H, Song J, Jiang X, Wang G, et al. Dysbacteriosis induces abnormal neurogenesis via LPS in a pathway requiring NF-\u03baB\/IL-6. Pharm Res. 2021;167:105543.","journal-title":"Pharm Res"},{"key":"8211_CR81","doi-asserted-by":"crossref","first-page":"e1007468","DOI":"10.1371\/journal.ppat.1007468","volume":"15","author":"L Holokai","year":"2019","unstructured":"Holokai L, Chakrabarti J, Broda T, Chang J, Hawkins JA, Sundaram N, et al. Increased programmed death-ligand 1 is an early epithelial cell response to Helicobacter pylori infection. PLOS Pathog. 2019;15:e1007468.","journal-title":"PLOS Pathog"},{"key":"8211_CR82","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/hel.12152","volume":"20","author":"MA Schumacher","year":"2015","unstructured":"Schumacher MA, Feng R, Aihara E, Engevik AC, Montrose MH, Ottemann KM, et al. Helicobacter pylori-induced Sonic Hedgehog expression is regulated by NF\u03baB pathway activation: the use of a novel in vitro model to study epithelial response to infection. Helicobacter. 2015;20:19\u201328.","journal-title":"Helicobacter"},{"key":"8211_CR83","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2022.935806","volume":"12","author":"S Groeger","year":"2022","unstructured":"Groeger S, Wu F, Wagenlehner F, Dansranjav T, Ruf S, Denter F, et al. PD-L1 up-regulation in prostate cancer cells by Porphyromonas gingivalis. Front Cell Infect Microbiol. 2022;12:935806.","journal-title":"Front Cell Infect Microbiol"},{"key":"8211_CR84","volume":"14","author":"Y Li","year":"2023","unstructured":"Li Y, Xing S, Chen F, Li Q, Dou S, Huang Y, et al. Intracellular Fusobacterium nucleatum infection attenuates antitumor immunity in esophageal squamous cell carcinoma. Nat Commun. 2023;14:5788.","journal-title":"Nat Commun"},{"key":"8211_CR85","volume":"16","author":"SY Lee","year":"2024","unstructured":"Lee SY, Jhun J, Woo JS, Lee KH, Hwang S-H, Moon J, et al. Gut microbiome-derived butyrate inhibits the immunosuppressive factors PD-L1 and IL-10 in tumor-associated macrophages in gastric cancer. Gut Microbes. 2024;16:2300846.","journal-title":"Gut Microbes"},{"key":"8211_CR86","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/j.cmet.2021.03.002","volume":"33","author":"Y He","year":"2021","unstructured":"He Y, Fu L, Li Y, Wang W, Gong M, Zhang J, et al. Gut microbial metabolites facilitate anticancer therapy efficacy by modulating cytotoxic CD8+ T cell immunity. Cell Metab. 2021;33:988\u20131000.e7.","journal-title":"Cell Metab"},{"key":"8211_CR87","doi-asserted-by":"crossref","first-page":"83155","DOI":"10.18632\/oncotarget.17950","volume":"8","author":"L Booth","year":"2017","unstructured":"Booth L, Roberts JL, Poklepovic A, Kirkwood J, Dent P. HDAC inhibitors enhance the immunotherapy response of melanoma cells. Oncotarget. 2017;8:83155\u201370.","journal-title":"Oncotarget"},{"key":"8211_CR88","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.mib.2020.09.001","volume":"56","author":"NV Andreeva","year":"2020","unstructured":"Andreeva NV, Gabbasova RR, Grivennikov SI. Microbiome in cancer progression and therapy. Curr Opin Microbiol. 2020;56:118\u201326.","journal-title":"Curr Opin Microbiol"},{"key":"8211_CR89","volume":"4","author":"Z Zhang","year":"2023","unstructured":"Zhang Z, Gao Q, Ren X, Luo M, Liu Y, Liu P, et al. Characterization of intratumor microbiome in cancer immunotherapy. Innov Camb Mass. 2023;4:100482.","journal-title":"Innov Camb Mass"},{"key":"8211_CR90","doi-asserted-by":"crossref","first-page":"e000973","DOI":"10.1136\/jitc-2020-000973","volume":"8","author":"L Shi","year":"2020","unstructured":"Shi L, Sheng J, Chen G, Zhu P, Shi C, Li B, et al. Combining IL-2-based immunotherapy with commensal probiotics produces enhanced antitumor immune response and tumor clearance. J Immunother Cancer. 2020;8:e000973.","journal-title":"J Immunother Cancer"},{"key":"8211_CR91","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1136\/gutjnl-2020-323392","volume":"71","author":"P Oster","year":"2022","unstructured":"Oster P, Vaillant L, Riva E, McMillan B, Begka C, Truntzer C, et al. Helicobacter pylori infection has a detrimental impact on the efficacy of cancer immunotherapies. Gut. 2022;71:457\u201366.","journal-title":"Gut"},{"key":"8211_CR92","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abo2003","volume":"8","author":"Y Choi","year":"2023","unstructured":"Choi Y, Lichterman JN, Coughlin LA, Poulides N, Li W, Del Valle P, et al. Immune checkpoint blockade induces gut microbiota translocation that augments extraintestinal antitumor immunity. Sci Immunol. 2023;8:eabo2003.","journal-title":"Sci Immunol"},{"key":"8211_CR93","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/j.ccell.2018.03.004","volume":"33","author":"H Tilg","year":"2018","unstructured":"Tilg H, Adolph TE, Gerner RR, Moschen AR. The intestinal microbiota in colorectal cancer. Cancer Cell. 2018;33:954\u201364.","journal-title":"Cancer Cell"},{"key":"8211_CR94","volume":"217","author":"Y Shi","year":"2020","unstructured":"Shi Y, Zheng W, Yang K, Harris KG, Ni K, Xue L, et al. Intratumoral accumulation of gut microbiota facilitates CD47-based immunotherapy via STING signaling. J Exp Med. 2020;217:e20192282.","journal-title":"J Exp Med"},{"key":"8211_CR95","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1136\/gutjnl-2023-329543","volume":"72","author":"W Fong","year":"2023","unstructured":"Fong W, Li Q, Ji F, Liang W, Lau HCH, Kang X, et al. Lactobacillus gallinarum-derived metabolites boost anti-PD1 efficacy in colorectal cancer by inhibiting regulatory T cells through modulating IDO1\/Kyn\/AHR axis. Gut. 2023;72:2272\u201385.","journal-title":"Gut"},{"key":"8211_CR96","volume":"8","author":"OY Kim","year":"2017","unstructured":"Kim OY, Park HT, Dinh NTH, Choi SJ, Lee J, Kim JH, et al. Bacterial outer membrane vesicles suppress tumor by interferon-\u03b3-mediated antitumor response. Nat Commun. 2017;8:626.","journal-title":"Nat Commun"},{"key":"8211_CR97","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.cmet.2022.02.010","volume":"34","author":"H Wang","year":"2022","unstructured":"Wang H, Rong X, Zhao G, Zhou Y, Xiao Y, Ma D, et al. The microbial metabolite trimethylamine N-oxide promotes antitumor immunity in triple-negative breast cancer. Cell Metab. 2022;34:581\u201394.e8.","journal-title":"Cell Metab"},{"key":"8211_CR98","doi-asserted-by":"crossref","first-page":"8971","DOI":"10.1021\/acsnano.3c12687","volume":"18","author":"S Geng","year":"2024","unstructured":"Geng S, Guo P, Li X, Shi Y, Wang J, Cao M, et al. Biomimetic nanovehicle-enabled targeted depletion of intratumoral Fusobacterium nucleatum synergizes with PD-L1 blockade against breast cancer. ACS Nano. 2024;18:8971\u201387.","journal-title":"ACS Nano"},{"key":"8211_CR99","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2023.188943","volume":"1878","author":"J Qian","year":"2023","unstructured":"Qian J, Zhang X, Wei B, Tang Z, Zhang B. The correlation between gut and intra-tumor microbiota and PDAC: Etiology, diagnostics and therapeutics. Biochim Biophys Acta Rev Cancer. 2023;1878:188943.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"8211_CR100","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1038\/s41590-020-0761-y","volume":"21","author":"J Leinwand","year":"2020","unstructured":"Leinwand J, Miller G. Regulation and modulation of antitumor immunity in pancreatic cancer. Nat Immunol. 2020;21:1152\u20139.","journal-title":"Nat Immunol"},{"key":"8211_CR101","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1053\/j.gastro.2018.12.038","volume":"156","author":"VP Balachandran","year":"2019","unstructured":"Balachandran VP, Beatty GL, Dougan SK. Broadening the impact of immunotherapy to pancreatic cancer: challenges and opportunities. Gastroenterology. 2019;156:2056\u201372.","journal-title":"Gastroenterology"},{"key":"8211_CR102","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1038\/s41586-021-03368-8","volume":"592","author":"S Kalaora","year":"2021","unstructured":"Kalaora S, Nagler A, Nejman D, Alon M, Barbolin C, Barnea E, et al. Identification of bacteria-derived HLA-bound peptides in melanoma. Nature. 2021;592:138\u201343.","journal-title":"Nature"},{"key":"8211_CR103","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1126\/science.aan3706","volume":"359","author":"B Routy","year":"2018","unstructured":"Routy B, Le Chatelier E, Derosa L, Duong CPM, Alou MT, Daill\u00e8re R, et al. Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors. Science. 2018;359:91\u201397.","journal-title":"Science"},{"key":"8211_CR104","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/nature24462","volume":"551","author":"VP Balachandran","year":"2017","unstructured":"Balachandran VP, \u0141uksza M, Zhao JN, Makarov V, Moral JA, Remark R, et al. Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer. Nature. 2017;551:512\u20136.","journal-title":"Nature"},{"key":"8211_CR105","volume":"13","author":"Y Huang","year":"2022","unstructured":"Huang Y, Zhu N, Zheng X, Liu Y, Lu H, Yin X, et al. Intratumor microbiome analysis identifies positive association between megasphaera and survival of chinese patients with pancreatic ductal adenocarcinomas. Front Immunol. 2022;13:785422.","journal-title":"Front Immunol"},{"key":"8211_CR106","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/s41575-022-00631-9","volume":"19","author":"PD Cani","year":"2022","unstructured":"Cani PD, Depommier C, Derrien M, Everard A, de Vos WM. Akkermansia muciniphila: paradigm for next-generation beneficial microorganisms. Nat Rev Gastroenterol Hepatol. 2022;19:625\u201337.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"8211_CR107","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1001\/jamaoncol.2022.2810","volume":"8","author":"H Qiao","year":"2022","unstructured":"Qiao H, Tan X-R, Li H, Li J-Y, Chen X-Z, Li Y-Q, et al. Association of intratumoral microbiota with prognosis in patients with nasopharyngeal carcinoma from 2 hospitals in China. JAMA Oncol. 2022;8:1301\u20139.","journal-title":"JAMA Oncol"},{"key":"8211_CR108","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-86816-9","volume":"11","author":"C Neuzillet","year":"2021","unstructured":"Neuzillet C, Marchais M, Vacher S, Hilmi M, Schnitzler A, Meseure D, et al. Prognostic value of intratumoral Fusobacterium nucleatum and association with immune-related gene expression in oral squamous cell carcinoma patients. Sci Rep. 2021;11:7870.","journal-title":"Sci Rep"},{"key":"8211_CR109","volume":"9","author":"Y Xue","year":"2018","unstructured":"Xue Y, Xiao H, Guo S, Xu B, Liao Y, Wu Y, et al. Indoleamine 2,3-dioxygenase expression regulates the survival and proliferation of Fusobacterium nucleatum in THP-1-derived macrophages. Cell Death Dis. 2018;9:355.","journal-title":"Cell Death Dis"},{"key":"8211_CR110","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1158\/2326-6066.CIR-20-0196","volume":"8","author":"T Hakozaki","year":"2020","unstructured":"Hakozaki T, Richard C, Elkrief A, Hosomi Y, Benla\u00effaoui M, Mimpen I, et al. The gut microbiome associates with immune checkpoint inhibition outcomes in patients with advanced non-small cell lung cancer. Cancer Immunol Res. 2020;8:1243\u201350.","journal-title":"Cancer Immunol Res"},{"key":"8211_CR111","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.ccell.2020.02.006","volume":"37","author":"H Liu","year":"2020","unstructured":"Liu H, Kuang X, Zhang Y, Ye Y, Li J, Liang L, et al. ADORA1 inhibition promotes tumor immune evasion by regulating the ATF3-PD-L1 axis. Cancer Cell. 2020;37:324\u201339.e8.","journal-title":"Cancer Cell"},{"key":"8211_CR112","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/s41392-021-00795-x","volume":"6","author":"Y Gao","year":"2021","unstructured":"Gao Y, Bi D, Xie R, Li M, Guo J, Liu H, et al. Fusobacterium nucleatum enhances the efficacy of PD-L1 blockade in colorectal cancer. Signal Transduct Target Ther. 2021;6:398.","journal-title":"Signal Transduct Target Ther"},{"key":"8211_CR113","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1016\/j.ccell.2024.08.019","volume":"42","author":"X Wang","year":"2024","unstructured":"Wang X, Fang Y, Liang W, Wong CC, Qin H, Gao Y, et al. Fusobacterium nucleatum facilitates anti-PD-1 therapy in microsatellite stable colorectal cancer. Cancer Cell. 2024;42:1729\u201346.e8.","journal-title":"Cancer Cell"},{"key":"8211_CR114","first-page":"PO.17.00073","volume":"2017","author":"R Bonneville","year":"2017","unstructured":"Bonneville R, Krook MA, Kautto EA, Miya J, Wing MR, Chen H-Z, et al. Landscape of microsatellite instability across 39 cancer types. JCO Precis Oncol. 2017;2017:PO.17.00073.","journal-title":"JCO Precis Oncol"},{"key":"8211_CR115","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1002\/path.5894","volume":"257","author":"MA Glaire","year":"2022","unstructured":"Glaire MA, Ryan NA, Ijsselsteijn ME, Kedzierska K, Obolenski S, Ali R, et al. Discordant prognosis of mismatch repair deficiency in colorectal and endometrial cancer reflects variation in antitumour immune response and immune escape. J Pathol. 2022;257:340\u201351.","journal-title":"J Pathol"},{"key":"8211_CR116","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1093\/jnci\/djad083","volume":"115","author":"DA Byrd","year":"2023","unstructured":"Byrd DA, Fan W, Greathouse KL, Wu MC, Xie H, Wang X. The intratumor microbiome is associated with microsatellite instability. J Natl Cancer Inst. 2023;115:989\u201393.","journal-title":"J Natl Cancer Inst"},{"key":"8211_CR117","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.ccell.2022.01.003","volume":"40","author":"A Alam","year":"2022","unstructured":"Alam A, Levanduski E, Denz P, Villavicencio HS, Bhatta M, Alhorebi L, et al. Fungal mycobiome drives IL-33 secretion and type 2 immunity in pancreatic cancer. Cancer Cell. 2022;40:153\u201367.e11.","journal-title":"Cancer Cell"},{"key":"8211_CR118","doi-asserted-by":"crossref","DOI":"10.3389\/froh.2024.1360340","volume":"5","author":"JS Monteiro","year":"2024","unstructured":"Monteiro JS, Kaushik K, de Arruda JAA, Georgakopoulou E, Vieira AT, Silva TA, et al. Fungal footprints in oral cancer: unveiling the oral mycobiome. Front Oral Health. 2024;5:1360340.","journal-title":"Front Oral Health"},{"key":"8211_CR119","volume":"3","author":"D Wu","year":"2024","unstructured":"Wu D, Guan Y, Li C, Zheng Q, Yin Z, Wang H, et al. Nutrient\u2013fungi\u2013host\u201d tripartite interaction in cancer progression. iMeta. 2024;3:e170.","journal-title":"iMeta"},{"key":"8211_CR120","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.immuni.2025.02.005","volume":"58","author":"D Denk","year":"2025","unstructured":"Denk D, Ramakrishnan M, Conche C, Pallangyo C, Pesic M, Ceteci F, et al. IL-17RA signaling provides dual tumor-suppressor function during late-stage colorectal carcinogenesis. Immunity. 2025;58:701\u2013715.e8.","journal-title":"Immunity"},{"key":"8211_CR121","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1016\/j.cell.2024.03.021","volume":"187","author":"TW Battaglia","year":"2024","unstructured":"Battaglia TW, Mimpen IL, Traets JJH, van Hoeck A, Zeverijn LJ, Geurts BS, et al. A pan-cancer analysis of the microbiome in metastatic cancer. Cell. 2024;187:2324\u201335.e19.","journal-title":"Cell"},{"key":"8211_CR122","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1126\/science.add9667","volume":"378","author":"CR Gurbatri","year":"2022","unstructured":"Gurbatri CR, Arpaia N, Danino T. Engineering bacteria as interactive cancer therapies. Science. 2022;378:858\u201364.","journal-title":"Science"},{"key":"8211_CR123","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1158\/1078-0432.CCR-20-2065","volume":"27","author":"F Janku","year":"2021","unstructured":"Janku F, Zhang HH, Pezeshki A, Goel S, Murthy R, Wang-Gillam A, et al. Intratumoral injection of Clostridium novyi-NT spores in patients with treatment-refractory advanced solid tumors. Clin Cancer Res J Am Assoc Cancer Res. 2021;27:96\u2013106.","journal-title":"Clin Cancer Res J Am Assoc Cancer Res"},{"key":"8211_CR124","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.canlet.2016.10.034","volume":"385","author":"X Wang","year":"2017","unstructured":"Wang X, Wei S, Zhao Y, Shi C, Liu P, Zhang C, et al. Anti-proliferation of breast cancer cells with itraconazole: Hedgehog pathway inhibition induces apoptosis and autophagic cell death. Cancer Lett. 2017;385:128\u201336.","journal-title":"Cancer Lett"},{"key":"8211_CR125","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s12672-023-00670-x","volume":"14","author":"Y Liang","year":"2023","unstructured":"Liang Y, Li Q, Liu Y, Guo Y, Li Q. Awareness of intratumoral bacteria and their potential application in cancer treatment. Discov Oncol. 2023;14:57.","journal-title":"Discov Oncol"},{"key":"8211_CR126","volume":"11","author":"X-T Xie","year":"2025","unstructured":"Xie X-T, Guan M, Cheng K, Li Y, Zhang B, Zhou Y-T, et al. Programmable engineered bacteria as sustained-releasing antibody factory in situ for enhancing tumor immune checkpoint therapy. Sci Adv. 2025;11:eadt7298.","journal-title":"Sci Adv"},{"key":"8211_CR127","doi-asserted-by":"crossref","first-page":"329","DOI":"10.3390\/vaccines9040329","volume":"9","author":"Y Ikeda","year":"2021","unstructured":"Ikeda Y, Adachi K, Tomio K, Eguchi-Kojima S, Tsuruga T, Uchino-Mori M, et al. A placebo-controlled, double-blind randomized (Phase IIB) trial of oral administration with HPV16 E7-expressing lactobacillus, GLBL101c, for the treatment of cervical intraepithelial neoplasia grade 2 (CIN2). Vaccines. 2021;9:329.","journal-title":"Vaccines"},{"key":"8211_CR128","doi-asserted-by":"crossref","first-page":"3423","DOI":"10.1016\/j.vaccine.2018.05.009","volume":"36","author":"A Komatsu","year":"2018","unstructured":"Komatsu A, Igimi S, Kawana K. Optimization of human papillomavirus (HPV) type 16 E7-expressing lactobacillus-based vaccine for induction of mucosal E7-specific IFN\u03b3-producing cells. Vaccine. 2018;36:3423\u20136.","journal-title":"Vaccine"},{"key":"8211_CR129","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1016\/j.cell.2025.02.002","volume":"188","author":"Z Chang","year":"2025","unstructured":"Chang Z, Guo X, Li X, Wang Y, Zang Z, Pei S, et al. Bacterial immunotherapy leveraging IL-10R hysteresis for both phagocytosis evasion and tumor immunity revitalization. Cell. 2025;188:1842\u201357.e20.","journal-title":"Cell"},{"key":"8211_CR130","doi-asserted-by":"crossref","first-page":"viii732","DOI":"10.1093\/annonc\/mdy424.050","volume":"29","author":"CM Rudin","year":"2018","unstructured":"Rudin CM, Pandha HS, Gupta S, Zibelman MR, Akerley W, Day D, et al. Phase Ib KEYNOTE-200: A study of an intravenously delivered oncolytic virus, coxsackievirus A21 in combination with pembrolizumab in advanced NSCLC and bladder cancer patients. Ann Oncol. 2018;29:viii732.","journal-title":"Ann Oncol"},{"key":"8211_CR131","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/S1470-2045(15)00483-0","volume":"17","author":"E Quoix","year":"2016","unstructured":"Quoix E, Lena H, Losonczy G, Forget F, Chouaid C, Papai Z, et al. TG4010 immunotherapy and first-line chemotherapy for advanced non-small-cell lung cancer (TIME): results from the phase 2b part of a randomised, double-blind, placebo-controlled, phase 2b\/3 trial. Lancet Oncol. 2016;17:212\u201323.","journal-title":"Lancet Oncol"},{"key":"8211_CR132","volume":"15","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Xi K, Fu Z, Zhang Y, Cheng B, Feng F, et al. Stimulation of tumoricidal immunity via bacteriotherapy inhibits glioblastoma relapse. Nat Commun. 2024;15:4241.","journal-title":"Nat Commun"},{"key":"8211_CR133","volume":"9","author":"JH Zheng","year":"2017","unstructured":"Zheng JH, Nguyen VH, Jiang S-N, Park S-H, Tan W, Hong SH, et al. Two-step enhanced cancer immunotherapy with engineered Salmonella typhimurium secreting heterologous flagellin. Sci Transl Med. 2017;9:eaak9537.","journal-title":"Sci Transl Med"},{"key":"8211_CR134","doi-asserted-by":"crossref","first-page":"3756","DOI":"10.1038\/s41388-019-0681-1","volume":"38","author":"M Vitiello","year":"2019","unstructured":"Vitiello M, Evangelista M, Di Lascio N, Kusmic C, Massa A, Orso F, et al. Antitumoral effects of attenuated Listeria monocytogenes in a genetically engineered mouse model of melanoma. Oncogene. 2019;38:3756\u201362.","journal-title":"Oncogene"},{"key":"8211_CR135","volume":"9","author":"D-W Zheng","year":"2018","unstructured":"Zheng D-W, Chen Y, Li Z-H, Xu L, Li C-X, Li B, et al. Optically-controlled bacterial metabolite for cancer therapy. Nat Commun. 2018;9:1680.","journal-title":"Nat Commun"},{"key":"8211_CR136","volume":"5","author":"Y Yang","year":"2024","unstructured":"Yang Y, Wang Y, Zeng F, Chen Y, Chen Z, Yan F. Ultrasound-visible engineered bacteria for tumor chemo-immunotherapy. Cell Rep Med. 2024;5:101512.","journal-title":"Cell Rep Med"},{"key":"8211_CR137","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/s41579-018-0029-9","volume":"16","author":"R Knight","year":"2018","unstructured":"Knight R, Vrbanac A, Taylor BC, Aksenov A, Callewaert C, Debelius J, et al. Best practices for analysing microbiomes. Nat Rev Microbiol. 2018;16:410\u201322.","journal-title":"Nat Rev Microbiol"},{"key":"8211_CR138","first-page":"32","volume":"1","author":"Z Gao","year":"2025","unstructured":"Gao Z, Jiang A, Li Z, Zhu L, Mou W, Shen W, et al. Heterogeneity of intratumoral microbiota within the tumor microenvironment and relationship to tumor development. Med Res. 2025;1:32\u201361.","journal-title":"Med Res"},{"key":"8211_CR139","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adj7402","volume":"10","author":"W Robinson","year":"2024","unstructured":"Robinson W, Stone JK, Schischlik F, Gasmi B, Kelly MC, Seibert C, et al. Identification of intracellular bacteria from multiple single-cell RNA-seq platforms using CSI-Microbes. Sci Adv. 2024;10:eadj7402.","journal-title":"Sci Adv"},{"key":"8211_CR140","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1038\/s41586-022-05435-0","volume":"611","author":"JL Galeano Ni\u00f1o","year":"2022","unstructured":"Galeano Ni\u00f1o JL, Wu H, LaCourse KD, Kempchinsky AG, Baryiames A, Barber B, et al. Effect of the intratumoral microbiota on spatial and cellular heterogeneity in cancer. Nature. 2022;611:810\u20137.","journal-title":"Nature"},{"key":"8211_CR141","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1016\/j.ccell.2023.09.012","volume":"41","author":"LE Colbert","year":"2023","unstructured":"Colbert LE, El Alam MB, Wang R, Karpinets T, Lo D, Lynn EJ, et al. Tumor-resident Lactobacillus iners confer chemoradiation resistance through lactate-induced metabolic rewiring. Cancer Cell. 2023;41:1945\u201362.e11.","journal-title":"Cancer Cell"},{"key":"8211_CR142","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.ccell.2021.03.004","volume":"39","author":"A Bertocchi","year":"2021","unstructured":"Bertocchi A, Carloni S, Ravenda PS, Bertalot G, Spadoni I, Lo Cascio A, et al. Gut vascular barrier impairment leads to intestinal bacteria dissemination and colorectal cancer metastasis to liver. Cancer Cell. 2021;39:708\u2013724.e11.","journal-title":"Cancer Cell"},{"key":"8211_CR143","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1200\/JCO.2014.57.4244","volume":"33","author":"DT Le","year":"2015","unstructured":"Le DT, Wang-Gillam A, Picozzi V, Greten TF, Crocenzi T, Springett G, et al. Safety and survival with GVAX pancreas prime and Listeria Monocytogenes-expressing mesothelin (CRS-207) boost vaccines for metastatic pancreatic cancer. J Clin Oncol J Am Soc Clin Oncol. 2015;33:1325\u201333.","journal-title":"J Clin Oncol J Am Soc Clin Oncol"},{"key":"8211_CR144","doi-asserted-by":"crossref","first-page":"3810","DOI":"10.3390\/cancers16223810","volume":"16","author":"CJ Thomas","year":"2024","unstructured":"Thomas CJ, Delgado K, Sawant K, Roy J, Gupta U, Song CS, et al. Harnessing bacterial agents to modulate the tumor microenvironment and enhance cancer immunotherapy. Cancers. 2024;16:3810.","journal-title":"Cancers"},{"key":"8211_CR145","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1136\/gutjnl-2017-314205","volume":"67","author":"RM Ferreira","year":"2018","unstructured":"Ferreira RM, Pereira-Marques J, Pinto-Ribeiro I, Costa JL, Carneiro F, Machado JC, et al. Gastric microbial community profiling reveals a dysbiotic cancer-associated microbiota. Gut. 2018;67:226\u201336.","journal-title":"Gut"},{"key":"8211_CR146","doi-asserted-by":"crossref","first-page":"5574","DOI":"10.1158\/1078-0432.CCR-16-1786","volume":"22","author":"K Yamamura","year":"2016","unstructured":"Yamamura K, Baba Y, Nakagawa S, Mima K, Miyake K, Nakamura K, et al. Human microbiome fusobacterium nucleatum in esophageal cancer tissue is associated with prognosis. Clin Cancer Res J Am Assoc Cancer Res. 2016;22:5574\u201381.","journal-title":"Clin Cancer Res J Am Assoc Cancer Res"},{"key":"8211_CR147","volume":"2","author":"A Javaheri","year":"2016","unstructured":"Javaheri A, Kruse T, Moonens K, Mej\u00edas-Luque R, Debraekeleer A, Asche CI, et al. Helicobacter pylori adhesin HopQ engages in a virulence-enhancing interaction with human CEACAMs. Nat Microbiol. 2016;2:16189.","journal-title":"Nat Microbiol"},{"key":"8211_CR148","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1136\/gutjnl-2017-314281","volume":"67","author":"OO Coker","year":"2018","unstructured":"Coker OO, Dai Z, Nie Y, Zhao G, Cao L, Nakatsu G, et al. Mucosal microbiome dysbiosis in gastric carcinogenesis. Gut. 2018;67:1024\u201332.","journal-title":"Gut"},{"key":"8211_CR149","first-page":"e00983","volume":"10","author":"J-H Huang","year":"2022","unstructured":"Huang J-H, Wang J, Chai X-Q, Li Z-C, Jiang Y-H, Li J, et al. The Intratumoral Bacterial Metataxonomic Signature of Hepatocellular Carcinoma. Microbiol Spectr. 2022;10:e00983\u201322.","journal-title":"Microbiol Spectr"},{"key":"8211_CR150","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1126\/science.aah5043","volume":"357","author":"LT Geller","year":"2017","unstructured":"Geller LT, Barzily-Rokni M, Danino T, Jonas OH, Shental N, Nejman D, et al. Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine. Science. 2017;357:1156\u201360.","journal-title":"Science"},{"key":"8211_CR151","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1038\/s41586-019-1608-2","volume":"574","author":"B Aykut","year":"2019","unstructured":"Aykut B, Pushalkar S, Chen R, Li Q, Abengozar R, Kim JI, et al. The fungal mycobiome promotes pancreatic oncogenesis via activation of MBL. Nature. 2019;574:264\u20137.","journal-title":"Nature"},{"key":"8211_CR152","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1126\/science.aal5240","volume":"358","author":"S Bullman","year":"2017","unstructured":"Bullman S, Pedamallu CS, Sicinska E, Clancy TE, Zhang X, Cai D, et al. Analysis of Fusobacterium persistence and antibiotic response in colorectal cancer. Science. 2017;358:1443\u20138.","journal-title":"Science"},{"key":"8211_CR153","doi-asserted-by":"crossref","first-page":"371","DOI":"10.3389\/fonc.2018.00371","volume":"8","author":"Z Zhou","year":"2018","unstructured":"Zhou Z, Chen J, Yao H, Hu H. Fusobacterium and colorectal cancer. Front Oncol. 2018;8:371.","journal-title":"Front Oncol"},{"key":"8211_CR154","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1038\/s41591-019-0458-7","volume":"25","author":"S Yachida","year":"2019","unstructured":"Yachida S, Mizutani S, Shiroma H, Shiba S, Nakajima T, Sakamoto T, et al. Metagenomic and metabolomic analyses reveal distinct stage-specific phenotypes of the gut microbiota in colorectal cancer. Nat Med. 2019;25:968\u201376.","journal-title":"Nat Med"},{"key":"8211_CR155","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1053\/j.gastro.2021.02.020","volume":"160","author":"W Liu","year":"2021","unstructured":"Liu W, Zhang X, Xu H, Li S, Lau HC-H, Chen Q, et al. Microbial community heterogeneity within colorectal neoplasia and its correlation with colorectal carcinogenesis. Gastroenterology. 2021;160:2395\u2013408.","journal-title":"Gastroenterology"},{"key":"8211_CR156","doi-asserted-by":"crossref","DOI":"10.1186\/s13073-017-0405-5","volume":"9","author":"H Wang","year":"2017","unstructured":"Wang H, Funchain P, Bebek G, Altemus J, Zhang H, Niazi F, et al. Microbiomic differences in tumor and paired-normal tissue in head and neck squamous cell carcinomas. Genome Med. 2017;9:14.","journal-title":"Genome Med"},{"key":"8211_CR157","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.04596-22","volume":"11","author":"R Pratap Singh","year":"2023","unstructured":"Pratap Singh R, Kumari N, Gupta S, Jaiswal R, Mehrotra D, Singh S, et al. Intratumoral microbiota changes with tumor stage and influences the immune signature of oral squamous cell carcinoma. Microbiol Spectr. 2023;11:e0459622.","journal-title":"Microbiol Spectr"},{"key":"8211_CR158","volume":"197","author":"Y Ma","year":"2024","unstructured":"Ma Y, Chen T, Sun T, Dilimulati D, Xiao Y. The oncomicrobiome: new insights into microorganisms in cancer. Micro Pathog. 2024;197:107091.","journal-title":"Micro Pathog"},{"key":"8211_CR159","doi-asserted-by":"crossref","first-page":"493","DOI":"10.3389\/fcimb.2017.00493","volume":"7","author":"J Lee","year":"2017","unstructured":"Lee J, Roberts JS, Atanasova KR, Chowdhury N, Han K, Yilmaz \u00d6. Human primary epithelial cells acquire an epithelial-mesenchymal-transition phenotype during long-term infection by the oral opportunistic pathogen, Porphyromonas gingivalis. Front Cell Infect Microbiol. 2017;7:493.","journal-title":"Front Cell Infect Microbiol"},{"key":"8211_CR160","volume":"17","author":"G Yu","year":"2016","unstructured":"Yu G, Gail MH, Consonni D, Carugno M, Humphrys M, Pesatori AC, et al. Characterizing human lung tissue microbiota and its relationship to epidemiological and clinical features. Genome Biol. 2016;17:163.","journal-title":"Genome Biol"},{"key":"8211_CR161","doi-asserted-by":"crossref","DOI":"10.1186\/s13059-018-1501-6","volume":"19","author":"KL Greathouse","year":"2018","unstructured":"Greathouse KL, White JR, Vargas AJ, Bliskovsky VV, Beck JA, von Muhlinen N, et al. Interaction between the microbiome and TP53 in human lung cancer. Genome Biol. 2018;19:123.","journal-title":"Genome Biol"},{"key":"8211_CR162","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1164\/rccm.201710-2118OC","volume":"198","author":"J-CJ Tsay","year":"2018","unstructured":"Tsay J-CJ, Wu BG, Badri MH, Clemente JC, Shen N, Meyn P, et al. Airway microbiota is associated with upregulation of the PI3K pathway in lung cancer. Am J Respir Crit Care Med. 2018;198:1188\u201398.","journal-title":"Am J Respir Crit Care Med"},{"key":"8211_CR163","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1158\/2159-8290.CD-20-0263","volume":"11","author":"J-CJ Tsay","year":"2021","unstructured":"Tsay J-CJ, Wu BG, Sulaiman I, Gershner K, Schluger R, Li Y, et al. Lower airway dysbiosis affects lung cancer progression. Cancer Discov. 2021;11:293\u2013307.","journal-title":"Cancer Discov"},{"key":"8211_CR164","doi-asserted-by":"crossref","first-page":"4182","DOI":"10.1038\/onc.2017.28","volume":"36","author":"C Jungnickel","year":"2017","unstructured":"Jungnickel C, Schmidt LH, Bittigkoffer L, Wolf L, Wolf A, Ritzmann F, et al. IL-17C mediates the recruitment of tumor-associated neutrophils and lung tumor growth. Oncogene. 2017;36:4182\u201390.","journal-title":"Oncogene"},{"key":"8211_CR165","doi-asserted-by":"crossref","first-page":"5039","DOI":"10.1128\/AEM.01235-16","volume":"82","author":"C Urbaniak","year":"2016","unstructured":"Urbaniak C, Gloor GB, Brackstone M, Scott L, Tangney M, Reid G. The microbiota of breast tissue and its association with breast cancer. Appl Environ Microbiol. 2016;82:5039\u201348.","journal-title":"Appl Environ Microbiol"},{"key":"8211_CR166","doi-asserted-by":"crossref","DOI":"10.1186\/s13073-021-00874-2","volume":"13","author":"A Tzeng","year":"2021","unstructured":"Tzeng A, Sangwan N, Jia M, Liu C-C, Keslar KS, Downs-Kelly E, et al. Human breast microbiome correlates with prognostic features and immunological signatures in breast cancer. Genome Med. 2021;13:60.","journal-title":"Genome Med"},{"key":"8211_CR167","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.semcancer.2020.07.010","volume":"70","author":"J Chadha","year":"2021","unstructured":"Chadha J, Nandi D, Atri Y, Nag A. Significance of human microbiome in breast cancer: Tale of an invisible and an invincible. Semin Cancer Biol. 2021;70:112\u201327.","journal-title":"Semin Cancer Biol"},{"key":"8211_CR168","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1158\/2159-8290.CD-20-0537","volume":"11","author":"S Parida","year":"2021","unstructured":"Parida S, Wu S, Siddharth S, Wang G, Muniraj N, Nagalingam A, et al. A procarcinogenic colon microbe promotes breast tumorigenesis and metastatic progression and concomitantly activates notch and \u03b2-catenin axes. Cancer Discov. 2021;11:1138\u201357.","journal-title":"Cancer Discov"},{"key":"8211_CR169","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/s41585-020-0286-z","volume":"17","author":"P \u0141aniewski","year":"2020","unstructured":"\u0141aniewski P, Ilhan ZE, Herbst-Kralovetz MM. The microbiome and gynaecological cancer development, prevention and therapy. Nat Rev Urol. 2020;17:232\u201350.","journal-title":"Nat Rev Urol"},{"key":"8211_CR170","volume":"8","author":"MRS Walther-Ant\u00f3nio","year":"2016","unstructured":"Walther-Ant\u00f3nio MRS, Chen J, Multinu F, Hokenstad A, Distad TJ, Cheek EH, et al. Potential contribution of the uterine microbiome in the development of endometrial cancer. Genome Med. 2016;8:122.","journal-title":"Genome Med"},{"key":"8211_CR171","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1080\/1040841X.2020.1794792","volume":"46","author":"DF Squarzanti","year":"2020","unstructured":"Squarzanti DF, Zavattaro E, Pizzimenti S, Amoruso A, Savoia P, Azzimonti B. Non-Melanoma Skin Cancer: news from microbiota research. Crit Rev Microbiol. 2020;46:433\u201349.","journal-title":"Crit Rev Microbiol"},{"key":"8211_CR172","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aao4502","volume":"4","author":"T Nakatsuji","year":"2018","unstructured":"Nakatsuji T, Chen TH, Butcher AM, Trzoss LL, Nam S-J, Shirakawa KT, et al. A commensal strain of Staphylococcus epidermidis protects against skin neoplasia. Sci Adv. 2018;4:eaao4502.","journal-title":"Sci Adv"},{"key":"8211_CR173","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2017.1303584","volume":"7","author":"FH Schmitz-Winnenthal","year":"2018","unstructured":"Schmitz-Winnenthal FH, Hohmann N, Schmidt T, Podola L, Friedrich T, Lubenau H, et al. A phase 1 trial extension to assess immunologic efficacy and safety of prime-boost vaccination with VXM01, an oral T cell vaccine against VEGFR2, in patients with advanced pancreatic cancer. Oncoimmunology. 2018;7:e1303584.","journal-title":"Oncoimmunology"},{"key":"8211_CR174","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/s41568-018-0070-z","volume":"18","author":"S Zhou","year":"2018","unstructured":"Zhou S, Gravekamp C, Bermudes D, Liu K. Tumour-targeting bacteria engineered to fight cancer. Nat Rev Cancer. 2018;18:727\u201343.","journal-title":"Nat Rev Cancer"},{"key":"8211_CR175","volume":"12","author":"Q Lin","year":"2021","unstructured":"Lin Q, Rong L, Jia X, Li R, Yu B, Hu J, et al. IFN-\u03b3-dependent NK cell activation is essential to metastasis suppression by engineered Salmonella. Nat Commun. 2021;12:2537.","journal-title":"Nat Commun"},{"key":"8211_CR176","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.2147\/OTT.S200414","volume":"12","author":"J Chen","year":"2019","unstructured":"Chen J, Lv Y, Mu F, Xu K. Long-term response of metastatic renal clear cell carcinoma following a subcutaneous injection of mixed bacterial vaccine: a case report. OncoTargets Ther. 2019;12:2531\u20138.","journal-title":"OncoTargets Ther"},{"key":"8211_CR177","doi-asserted-by":"crossref","first-page":"5787","DOI":"10.1158\/1078-0432.CCR-19-0070","volume":"25","author":"R Hassan","year":"2019","unstructured":"Hassan R, Alley E, Kindler H, Antonia S, Jahan T, Honarmand S, et al. Clinical response of live-attenuated, Listeria monocytogenes expressing mesothelin (CRS-207) with chemotherapy in patients with malignant pleural mesothelioma. Clin Cancer Res J Am Assoc Cancer Res. 2019;25:5787\u201398.","journal-title":"Clin Cancer Res J Am Assoc Cancer Res"},{"key":"8211_CR178","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.18632\/oncotarget.27536","volume":"11","author":"C Eng","year":"2020","unstructured":"Eng C, Fakih M, Amin M, Morris V, Hochster HS, Boland PM, et al. A phase II study of axalimogene filolisbac for patients with previously treated, unresectable, persistent\/recurrent loco-regional or metastatic anal cancer. Oncotarget. 2020;11:1334\u201343.","journal-title":"Oncotarget"},{"key":"8211_CR179","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1158\/1078-0432.CCR-23-0118","volume":"29","author":"JJ Luke","year":"2023","unstructured":"Luke JJ, Piha-Paul SA, Medina T, Verschraegen CF, Varterasian M, Brennan AM, et al. Phase I study of SYNB1891, an engineered E. coli nissle strain expressing STING agonist, with and without atezolizumab in advanced malignancies. Clin Cancer Res. 2023;29:2435\u201344.","journal-title":"Clin Cancer Res"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-08211-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-08211-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-08211-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T16:22:36Z","timestamp":1769098956000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-08211-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,1]]},"references-count":179,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8211"],"URL":"https:\/\/doi.org\/10.1038\/s41419-025-08211-w","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,1]]},"assertion":[{"value":"13 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All authors have approved to publish this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"62"}}